Hunan Jingfeng Pharmaceutical Co.,Ltd. manufactures and sells chemical drugs and biological agents in China. The company's principal product is sodium hyaluronate injection for use in orthopedics and surgery applications. It also offers ophthalmology and API products, as well as engages in the research and development of anti-tumor, cancer, and cardiovascular drugs; and provides skin care products. The company was founded in 2003 and is headquartered in Shanghai, China.

Nome	Capitalizzazione di mercato
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.	0M
Otsuka Holdings Co., Ltd.	0M
Merck & Co., Inc.	0M
Amgen Inc.	0M
JCR Pharmaceuticals Co., Ltd.	0M
Bristol-Myers Squibb Company	0M
GSK plc	0M
Luye Pharma Group Ltd.	0M
Mayne Pharma Group Limited	0M
Horizon Therapeutics Public Limited Company	0M

Hunan Jingfeng Pharmaceutical Co.,Ltd.

Hunan Jingfeng Pharmaceutical Co.,Ltd. Elenco dei concorrenti

Principali concorrenti